These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23291047)

  • 1. Biophysical characterization of the drug-membrane interactions: the case of propranolol and acebutolol.
    Pereira-Leite C; Carneiro C; Soares JX; Afonso C; Nunes C; Lúcio M; Reis S
    Eur J Pharm Biopharm; 2013 May; 84(1):183-91. PubMed ID: 23291047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of beta-blockers with model lipid membranes: molecular view of the interaction of acebutolol, oxprenolol, and propranolol with phosphatidylcholine vesicles by time-dependent fluorescence shift and molecular dynamics simulations.
    Först G; Cwiklik L; Jurkiewicz P; Schubert R; Hof M
    Eur J Pharm Biopharm; 2014 Aug; 87(3):559-69. PubMed ID: 24681296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of celecoxib with membranes: the role of membrane biophysics on its therapeutic and toxic effects.
    Pereira-Leite C; Nunes C; Lima JL; Reis S; Lúcio M
    J Phys Chem B; 2012 Nov; 116(46):13608-17. PubMed ID: 23094761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interactivities with lipid membranes differentially characterize selective and nonselective beta1-blockers.
    Mizogami M; Takakura K; Tsuchiya H
    Eur J Anaesthesiol; 2010 Sep; 27(9):829-34. PubMed ID: 20601889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic properties of acebutolol: relationship of hydrophilicity to central nervous system penetration.
    Abernethy DR; Arendt RM; Greenblatt DJ
    Am Heart J; 1985 May; 109(5 Pt 2):1120-5. PubMed ID: 2859774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative pharmacokinetics of beta-blockers].
    Kiechel JR; Meier J
    Nouv Presse Med; 1978 Sep; 7(31):2685-7. PubMed ID: 30943
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics, central nervous system uptake, and lipid solubility of propranolol, acebutolol, and sotalol.
    Arendt RM; Greenblatt DJ; deJong RH; Bonin JD; Abernethy DR
    Cardiology; 1984; 71(6):307-14. PubMed ID: 6151871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for enantiomer binding and separation of a common beta-blocker: crystal structure of cellobiohydrolase Cel7A with bound (S)-propranolol at 1.9 A resolution.
    Ståhlberg J; Henriksson H; Divne C; Isaksson R; Pettersson G; Johansson G; Jones TA
    J Mol Biol; 2001 Jan; 305(1):79-93. PubMed ID: 11114249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aqueous chlorination of acebutolol: kinetics, transformation by-products, and mechanism.
    Khalit WN; Tay KS
    Environ Sci Pollut Res Int; 2016 Feb; 23(3):2521-9. PubMed ID: 26423291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beta receptor blockaders. Pharmacokinetics and therapeutic effects].
    Bolte HD
    Internist (Berl); 1982 Nov; 23(11):616-23. PubMed ID: 6130051
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative ex vivo drug permeation study of beta-blockers through porcine buccal mucosa.
    Amores S; Lauroba J; Calpena A; Colom H; Gimeno A; Domenech J
    Int J Pharm; 2014 Jul; 468(1-2):50-4. PubMed ID: 24727142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1H and 13C NMR characteristics of β-blockers.
    Zielińska-Pisklak MA; Pisklak DM; Wawer I
    Magn Reson Chem; 2011 May; 49(5):284-90. PubMed ID: 21491484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of chosen beta-adrenolytic drugs of different polarity in basic environment.
    Kwiecień A; Krzek J; Zylewski M
    J AOAC Int; 2008; 91(2):322-31. PubMed ID: 18476343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and energetic evolution of fibrinogen toward to the betablocker interactions.
    González-Durruthy M; Scanavachi G; Rial R; Liu Z; Cordeiro MNDS; Itri R; Ruso JM
    Int J Biol Macromol; 2019 Sep; 137():405-419. PubMed ID: 31265849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the immobilized artificial membrane phosphatidylcholine. Drug discovery column for high-performance liquid chromatographic screening of drug-membrane interactions.
    Caldwell GW; Masucci JA; Evangelisto M; White R
    J Chromatogr A; 1998 Mar; 800(2):161-9. PubMed ID: 9561760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the beta-adrenergic blockers propranolol and acebutolol on stress-induced learned helplessness behavior of rats.
    Danchev N; Staneva-Stoytcheva D
    Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):463-7. PubMed ID: 8577208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathomimetic and cardiodepressant effects of acebutolol, oxprenolol, pindolol, and propranolol. A comparative study on changes in hemodynamics, contractility, heart rate, and AV-conduction time at therapeutic doses.
    Gülker H; Kristek J; Heuer H; Bender F
    Arzneimittelforschung; 1981; 31(9):1416-22. PubMed ID: 6118162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intrinsic sympathetic activity of beta-blockers on SA and AV nodes in man.
    Leclercq JF; Rosengarten MD; Kural S; Attuel P; Coumel P
    Eur J Cardiol; 1981; 12(6):367-75. PubMed ID: 6113145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biologic distribution of radioiodinated beta-adrenergic antagonists.
    Hanson RN; Holman BL; Davis MA
    J Med Chem; 1978 Aug; 21(8):830-3. PubMed ID: 29126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biotransformation and pharmacokinetics of beta-receptor blockaders].
    Pfeifer S; Zimmer C
    Pharmazie; 1975 Oct; 30(10):625-33. PubMed ID: 685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.